Back to Blog
Featured image for MeducationAI blog article: Hematology Oncology Board Review Courses Compared (2026): GW, MD Anderson, Harvard, ASCO and ASH

October 17, 2026

9 min read

Hematology Oncology Board Review Courses Compared (2026): GW, MD Anderson, Harvard, ASCO and ASH


Disclaimer: Clinical content is intended for professional education and is not a substitute for independent clinical judgment or current institutional protocols.

Written by Dr. Roupen Odabashian MD, FRCPC
Hematologist-Oncologist | Founder, MeDucation AI | Updated October 2026

The verdict: Most fellows do not need a multi-day board review course, and most programs should not default to paying for one every year. A course earns its seat time and its price tag in two situations: you want the CME/MOC credit bundle in one place, or you learn best from live, faculty-led lecture and want a single comprehensive pass through the blueprint before you start heavy question practice. If you're hematology-only, the GW Hematology Session or the Oakstone/Brigham Hematology course are the two worth comparing on price and format[1][2]. If you're medical oncology, GW's Oncology Session, the Oakstone/Brigham Oncology course, and ASH's review series (for hematology-malignancy-heavy content) are the realistic shortlist[3][4][5]. If your real constraint is money and PTO days rather than content gaps, skip the course and put the budget into a question bank you'll actually use daily — see our broader comparison of oncology board review question banks.

Conflict of interest, up front: I'm a practicing hematologist-oncologist and I founded MeDucation AI, which sells a physician-written heme/onc question bank and other board-prep tools. MeDucation does not run a live CME board review course, so this comparison is not me competing with these five programs — it's me telling you, as someone who sat the same exams, what a course actually buys you versus what a question bank buys you, and where I think your money is better spent.

Ranked summary: which course, if any, should you book?

Rank

Course

Best for

Why

1

GW Hematology and Medical Oncology Best Practices (Live or On-Demand)

Fellows wanting the most exam-hours-for-dollar live option

Largest published credit total of the group and separable hematology/oncology sessions[1][6]

2

Oakstone/Brigham and Dana-Farber Board Review

Fellows who want a self-paced, lower-cost enduring product with a pass guarantee

Published Board Pass Guarantee and flexible online/USB formats[2][4]

3

ASH Hematology Review Series

Hematology-only candidates who want live weekly study sessions through the whole prep season

Structured weekly schedule from June through the fall boards with live discussion[5]

4

MD Anderson/Baylor Board Review Study Materials

Fellows who want purchasable study materials rather than a dated course

Sold as study materials rather than a scheduled live course[7]

What do the 2026 heme/onc board review courses actually cost, and when do they run?

Prices and dates vary by format and by whether you book hematology-only, oncology-only, or the full course. Here is everything published, in one place.

Course

Organizer

Format

2026 Dates

CME Credits

Physician Price

HemOnc Best Practices — Full Live

GW School of Medicine

Live (in-person or virtual)

Aug 7–13, 2026[8]

Up to 61.00 AMA PRA Category 1[1]

Price varies by registrant type[1]

HemOnc Best Practices — Hematology Session (Live)

GW School of Medicine

Live (4-day)

Part of Aug 7–13, 2026 window[8]

Not separately published

Price varies by registrant type[1]

HemOnc Best Practices — On Demand (Full)

GW School of Medicine

On-demand/enduring

1-year access from purchase[6]

Up to 70.25 AMA PRA Category 1 (Full Course)[9]

$1,195 (Physician, Full Course)[9]

HemOnc Best Practices — On Demand (Hematology Only)

GW School of Medicine

On-demand/enduring

1-year access from purchase[6]

Up to 44.5 AMA PRA Category 1[9]

$1,195 (Physician)[9]

HemOnc Best Practices — On Demand (Oncology Only)

GW School of Medicine

On-demand/enduring

1-year access from purchase[6]

Up to 41.75 AMA PRA Category 1[9]

$1,195 (Physician)[9]

Brigham and Dana-Farber Board Review — Hematology

Oakstone Publishing

Enduring online (+ optional USB/syllabus)

Release March 15, 2025; expires March 14, 2028[2]

Up to 21.75 AMA PRA Category 1[2]

Not published in the source checked

Brigham and Dana-Farber Board Review — Oncology

Oakstone Publishing

Enduring online (+ optional USB/syllabus)

Release March 15, 2025; expires March 14, 2028[4]

Up to 28.25 AMA PRA Category 1[4]

Not published in the source checked

ASH Hematology Review Series

American Society of Hematology

Live weekly study sessions + recorded lectures

Lectures from June 26, 2026; weekly through Oct 15, 2026[5]

Not published in the source checked

Not published in the source checked

MD Anderson/Baylor HemOnc Board Review Study Materials

MD Anderson Cancer Center

Study materials (pre-order/purchase)

2026 materials listed as available for pre-order[7]

Not published in the source checked

Not published in the source checked

Is the GW Hematology and Medical Oncology Best Practices course worth it?

It is the most credit-dense live option on this list if you want an in-person or live-virtual format. GW's full live course is designated for up to 61.00 AMA PRA Category 1 Credits, and the on-demand full course goes even higher, up to 70.25 credits[1][9]. The course is explicitly structured around the ABIM exam blueprint, with named sessions on lymphomas, multiple myeloma, MDS, AML, BMT, lung, breast, GI, and genitourinary malignancies among others[3].

Empty lecture hall seating facing a stage, representing a live board review course

Is the Oakstone/Brigham and Dana-Farber Board Review worth it for hematology or oncology?

It's the one course on this list that explicitly guarantees your money back toward a retake if you don't pass. Oakstone states a "Board Pass Guarantee," offering extended access or credit toward a future program if you complete the course and don't pass your boards[2][4]. The hematology track carries up to 21.75 CME credits and covers molecular genetics, leukemia, lymphomas, and bone marrow disorders; the oncology track carries up to 28.25 credits and covers topics like multiple myeloma, Waldenström macroglobulinemia and amyloidosis, head and neck cancers, and NSCLC management[2][4].

The nuance: price is not published on the pages checked for this article, so you cannot comparison-shop it against GW's published figures without checking Oakstone's site directly at the time you book. It is also an enduring/self-paced product with a long access window — release was March 15, 2025, with termination March 14, 2028 — so it suits someone who wants flexibility over a live schedule, and it can be combined into a joint hematology-and-oncology bundle[2][4].

Is the ASH Hematology Review Series worth it?

It's the only option here built as a season-long live study cohort rather than a single multi-day event. ASH runs weekly subject-matter-expert lectures starting June 26, 2026, paired with live Thursday study sessions where participants work through board exam questions together, continuing through mid-October, timed to lead into the fall boards[5]. The published topic schedule is extensive and blueprint-organized: coagulation, hemolytic anemia, hemoglobinopathies, MDS, AML, ALL, lymphomas, CML, CLL, myeloma, and stem cell transplant/CAR-T, each assigned to a specific week[5].

Grid of small glowing windows representing a weekly series of study sessions

The nuance: this is hematology-only, so you'd need to confirm cost directly with ASH before budgeting it against the other options[5]. If you're a hematology-track fellow who learns best from a slow, paced structure rather than a condensed multi-day sprint, this format is genuinely different from GW or Oakstone and worth a look for that reason alone.

Is the MD Anderson/Baylor board review worth it?

It's listed as study materials available for pre-order rather than a scheduled live or on-demand course with its own dedicated page of dates and pricing. MD Anderson's continuing education page lists "The 2026 MD Anderson Cancer Center/Baylor College of Medicine Hematology and Medical Oncology Board Review Study Materials" as available for pre-order/purchase, alongside separate offerings like an Advanced Oncology Certified Nurse Practitioner review course and a hospice/palliative medicine board review[7].

The nuance: because this is framed as study materials rather than a dated course with a syllabus and live sessions, it's harder to compare apples-to-apples against GW or ASH on format and hours. If you're specifically drawn to MD Anderson and Baylor's name recognition, go to their continuing education page directly to confirm what's actually included and at what price before assuming it mirrors a live course experience.

Is there a Harvard heme/onc board review course?

Based on the sources checked for this article, no Harvard-branded hematology-oncology board review course page was found. If a Harvard-affiliated board review course exists, it isn't something this article can verify or price — check Harvard's own CME site directly rather than relying on secondhand claims, including this one. We'd rather tell you we didn't find it than guess.

Course or question bank: which moves your score more?

Neither format has a published, independently verified study in these sources directly comparing score gains from a multi-day course versus daily question practice, so this answer is reasoning, not a cited statistic. A board review course gives you concentrated exposure to a huge volume of content in a short window, which is valuable if you have real content gaps or haven't done a structured pass through the blueprint at all. But boards reward retrieval under exam conditions, not passive exposure to slides — and a week of lecture, however well taught, does not simulate the single-best-answer, vignette-based format you'll actually sit for.

That's the case for doing daily board-style questions with full explanations as the backbone of your prep, and treating a course (if you take one at all) as a supplement early in your timeline rather than a late-stage cram. We've written in detail about how to sequence a multi-month plan around question volume and spaced review in our complete ITE and ABIM strategy guide, and about what the final stretch should look like once you've already done your content review in our week-by-week plan from October 10 to November 18. If you're choosing between booking a live course and buying a year of question-bank access, and you can only afford one, the evidence from how boards are actually structured points toward questions.

FAQ

Do I need a board review course to pass the ABIM Hematology or Medical Oncology exam?

No course on this list is a requirement — all are optional, paid continuing education products, not ABIM-mandated prerequisites. Whether one helps you depends on whether you have genuine content gaps a lecture format will fix, versus needing retrieval practice a course format doesn't provide.

Which course covers the most CME credit hours?

Based on published figures, GW's on-demand full course offers the most at up to 70.25 AMA PRA Category 1 Credits, compared with up to 61.00 for its live full course[9][1].

References

  1. 2026 Hematology and Oncology Best Practices - Live Course Options | The George Washington University School of Medicine and Health Sciences

  2. Hematology Online CME from Brigham Board Review

  3. 2026 Hematology and Oncology Best Practices - Oncology Session | The George Washington University School of Medicine and Health Sciences

  4. Oncology Online CME from Brigham Board Review

  5. Hematology Review Series - Hematology.org

  6. Hematology and Medical Oncology Best Practices On Demand | Continuing Education | GW School of Medicine & Health Sciences

  7. Continuing Professional Education/Conferences | UT MD Anderson

  8. Live Courses | Continuing Education | GW School of Medicine & Health Sciences

  9. Hematology and Medical Oncology Best Practices Course | The George Washington University School of Medicine and Health Sciences

Frequently Asked Questions

This article is written for medical students, residents, fellows, and clinical educators looking for evidence-aligned guidance in oncology learning and board preparation.

No. This article is an educational resource and does not replace clinical judgment, institutional protocols, or specialty guideline updates.

Use it as a framework: review the key concepts, test yourself with practice questions, and pair your study with current guideline documents and physician-led teaching.

About the Author
Dr. Roupen Odabashian, MD, FRCPC

Dr. Roupen Odabashian, MD, FRCPC

Medical Oncologist

Medical oncologist at Abbotsford Regional Hospital, British Columbia; founder of MeDucation AI; clinical and research focus on thoracic oncology and AI in cancer care.

View full author profile
Ready to elevate your medical learning?

Join MeducationAI, the AI-powered medical education platform built for students across specialties, with personalized tutoring, smart study tools, and realistic clinical case simulations.

Get Started

Share this article